Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: Relevance for major depression and antidepressant mechanisms

Journal of Neurochemistry

Volumn 83, Issue 5, 2002, Pages 1054-1064

  Laifenfeld, Daphna ^a   Klein, Ehud ^a   Ben Shachar, Dorit ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Depression; Differentiation; GAP 43; Laminin; Neural cell adhesion L1; Norepinephrine

Indexed keywords

BETA ACTIN; CALCIUM BINDING PROTEIN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LAMININ; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NEUROMODULIN; NORADRENALIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; RETINOIC ACID; RNA;

ARTICLE; CONTROLLED STUDY; DEPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SURVIVAL; DEPRESSIVE DISORDER, MAJOR; DNA-BINDING PROTEINS; GAP-43 PROTEIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LAMININ; NEURAL CELL ADHESION MOLECULE L1; NEURITES; NEUROBLASTOMA; NEURONAL PLASTICITY; NEURONS; NOREPINEPHRINE; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0036892117     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01215.x     Document Type: Article

References (67)

1. Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki K. L. and Tzukerman M. (2001) Insulin production by human embryonic stem cells. Diabetes 50, 1691-1697.
2. Aston-Jones G., Akaoka H., Charlety P. and Chouvet G. (1991) Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J. Neurosci. 11, 760-769.
3. Banerjee S. P., Kung L. S., Riggi S. J. and Chanda S. K. (1977) Development of beta-adrenergic receptor subsensitivity by anti-depressants. Nature 268, 455-456.
4. Baraban J. M. and Aghajanian G. K. (1980) Supression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacol. 19, 355.
5. Benowitz L. I. and Routtenberg A. (1997) GAP-43: An intrinsic determinant of neuronal development and plastcity. Trends Neurosci. 20, 84-91.
6. 2 receptor characteristics in rat brain. Brain Res. 81, 678-683.
7. Biagioni S., Tata A. M., De Jaco A. and Augusti-Tocco G. (2000) Acetylcholine synthesis and neuron differentiation. Int. J. Rev. Biol. 44, 689-697.
8. Blandina P., Goldfarb J., Walcott J. and Green J. P. (1991) Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J. Pharmacol. Exp. Ther. 256, 341-347.
9. Blier P. and de Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
10. Bremner J. D., Narayan M., Anderson E. R., Staib L. H., Miller H. L. and Charney D. S. (2000) Hippocampal volume reduction in major depression. Am. J. Psychiatry 157, 115-118.
11. Cleare A. J., Murray R. M. and O'Keane V. (1997) Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Psychopharmacology 134, 406-410.
12. Crossin K. L. and Krushel L. A. (2000) Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev. Dyn. 21, 8260-8279.
13. Diamond D. M. and Rose G. M. (1994) Stress impairs LTP and hippocampal-dependent memory. Ann. NY Acad. Sci. 30, 411-414.
14. Drevets W. C., Price J. L., Simpson J. R., Todd R. D., Reich T., Vannier M. and Raichle M. E. (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
15. Duman R. S., Heninger G. R. and Nestler E. J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606.
16. Dziadek M. (1995) Role of laminin-nidogen complexes in basement membrane formation during develoment. Experientia 51, 901-913.
17. Evans T. R. and Kaye S. B. (1999) Retinoids present role and future potential. Br. J. Cancer 80, 1-8.
18. Ferry B. and McGaugh J. (1999) Clenbuterol administration into the basolateral amygdala post-training enhances retention in an inhibitory avoidance task. Neurobiol. Learn. Mem. 72, 8-12.
19. Ferry B., Roozendaal B. and McGaugh J. (1999) Basolateral amygdala noradrenergic influence on memory storage are mediated by an interaction between β- and α1-adrenoceptors. J. Neurosci. 19, 5119-5123.
20. Fiorica-Howells E., Maroteaux L. and Gershon M. D. (2000) Serotonin and the 5-HT (2B) receptor in the development of enteric neurons. J. Neurosci. 20, 294-305.
21. Fozard J. R. (1984) Neuronal 5-HT receptors in the periphery. Neuropharmacol. 23, 1473-1486.
22. Freis E. (1954) Mental depression in hypertensives treated for long periods with large doses of reserpine. N. Engl. J. Med. 251, 1006-1008.
23. Hager G., Pawelzik H., Kreutzberg G. W. and Zieglgansberger W. (1998) A peptide derived from a neurite outgrowth-promoting domain on the gamma 1 chain of lamini modulates the electrical properties of neocortical neurons. Neuroscience 86, 1145-1154.
24. Hall H., Carbonetto S. and Schachner M. (1997) L1/HNK-1 carbohydrate- and β1 integrin-dependent neural cell adhesion to laminin-1. J. Neurochem. 68, 544-553.
25. Hall H., Bozic D., Fause C. and Engel J. (2000) Trimerization of cell adhesion molecule L1 mimics clustered L1 expression on the cell surface influence on L1-ligand interactioons and on promotion of neurite outgrowth. J. Neurochem. 75, 336-346.
26. Hewson Q. C., Lova P. E., Malcolm A. J., Pearson A. D. and Redfern C. P. (2000) Receptor mechanisms mediating differentiation and proliferation effects of retiniods on neuroblastoma cells. Neurosci. Lett. 279, 113-116.
27. Honer W. G., Falkai P., Chen C., Arango V., Mann J. J. and Dwork A. J. (1999) Synaptic and plasticity-associated proteins in anterior frontal cortex severe mental illness. Neuroscience 91, 1247-1255.
28. Hopkins W. F. and Johnston D. (1984) Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 226, 350-352.
29. Hrdina P., Faludi G., Li Q., Bendotti C., Tekes K., Sotonyi P. and Palkovits M. (1998) Growth-associated protein (GAP-43), its mRNA and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol. Psychiatry 3, 411-418.
30. Kaplan D. R., Matsumoto K., Lucarelli E. and Thiele C. J. (1993) Induction of Trk B by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 11, 321-331.
31. Kitayama I., Yaga T., Kayahara T., Nakano K., Murase S., Otani M. and Nomura J. (1997) Long-term stress degenerates, but impramine regenerates, noradrenergic axons in the rat cerbral cortex. Biol. Psychiatry 42, 687-696.
32. Klesse L. J. and Parada L. E (1999) Trks signal transduction and intracellular pathways. Microscopy Res. Tech. 45, 210-216.
33. Leslie F. M. (1993) Neurotransmitters as neurotrophic factors, in Neurotrophic Factors (Loughlin S. E. and Fallon J. H., eds), pp. 565-598. Academic press, Orlando.
34. Luthl A., Laurent J. P., Figurov A., Muller D. and Schachner M. (1994) Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM. Nature 37, 2777-2779.
35. Maas J., Fawcett J. and Dekirmenjian H. (1972) Catecholamine metabolism, depressive illness and drug response. Arch. Gen. Psychiatry 26, 252-262.
36. Madhav T. R., Pei Q., Grahame-Smith D. G. and Zetterstrom T. S. C. (2000) Repeated electrocunvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus. Neuroscience 97, 677-683.
37. Manji H. K., Moorie G. J., Rajkouvska G. and Chen G. (2000) Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry 55, 78-93.
38. Mehlen P., Coronas V., Ljubic-Thibal V., Ducasse C., Granger L., Jourdan F. and Arrigo A. P. (1999) Small stress protein Hsp27 accumulation during dompamine-mediated differentiation of rat olfactory meurons counteracts apoptosis. Cell Death Diff. 6, 227-233.
39. Meier H., Herts L. and Schousboe A. (1991) Neurotransmitters as developmental signals. Neurochem. Int. XX, 191-215.
40. Meiri K. F., Saffell J. L., Walsh F. S. and Doherty P. (1998) Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. J. Neurosci. 18, 10429-10437.
41. Menkes D. B., Rasenick M. M., Wheeler M. A. and Bitensky M. W. (1983) Guanosine triphosphate activation of brain adenylate cyclase enhancement by long-term antidepressant treatment. Science 219, 65-67.
42. Muller J., Pryer W., Gibbons J. and Orgain E. (1955) Depression and anxiety occurring during Rauwolfia therapy. JAMA 15, 9836-9839.
43. Muscettola G., Potter W. Z., Pickar D. and Goodwin F. K. (1984) Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Arch. Gen. Psychiatry 41, 337-342.
44. Nestler E. J., Terwilliger R. Z. and Duman R. S. (1989) Chronic anti-depressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53, 1644-1647.
45. Nibuya M., Nestler E. J. and Duman R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365-2372.
46. 2-, and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J. Biol. Chem. 273, 24624-24632.
47. Oestreicher E., Knipper M., Arnold A., Zenner H. P. and Felix D. (2000) Neurotrophin 3 potentiates glutamatergic responses of IHC afferents in the cochlea in vivo. Eur. J. Neurosci. 12, 1584-1590.
48. Ongur D., Drevets W. C. and Price J. L. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibing N-methyl-D-aspartate receptor mediated calcium influx. Proc. Natl. Acad. Sci. USA 95, 13290-13295.
49. Owens M. J. (1997) Molecular and cellular mechanisms of antidepressant drugs. Depress. Anxiety 41, 53-59.
50. Peroutka S. L. and Snyder S. H. (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210, 88-90.
51. Popoli M., Brunello N., Perez J. and Racagni G. (2000) Second messenger-regulated protein kinases in the brain, their functional role and the action of antidepressant drugs. J. Neurochem. 74, 21-33.
52. Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S. D., Meltzer H. Y. et al. (1999) Morphometric evidence for neuronal and glial prefrontal cell patholgy in major depression. Biol. Psychiatry 45, 1085-1098.
53. Ressler K. J. and Nemeroff C. B. (1999) Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol. Psychiatry 46, 1219-1233.
54. 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum a microdialysis study. Eur. J. Pharmacol. 26, 59-65.
55. Rowe S. J., Messenger N. J. and Warner A. E. (1993) The role of noradrenaline in the differentiation of amphibian embryonic neurons. Development 119, 1343-1357.
56. Schatzberg A. F., Samson J. A., Bloomingdale K. L., Orsulak P. J., Gerson B., Kizuka P. P., Cole J. O. and Schildkraut J. J. (1989) Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Arch. Gen. Psychiatry 4, 260-268.
57. Schmidt U., Pilgrim C. and Beger C. (1998) Differentiative effects of dopamine on striatal neurons involve stimulation of the cAMP/PKA pathway. Mol. Cell. Neurosci. 11, 9-18.
58. Scholey A. B., Mileusnic R., Schachner M. and Rose S. P. (1995) A role for a chicken homolog of the neural cell adhesion molecule L1 in consolidation of memory for a passive avoidance task in the chick. Learn. Mem. XX, 217-225.
59. Sheline Y. I., Wang P. W., Gado M. H., Csemansky J. G. and Vannier M. W. (1996) Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93, 3908-3913.
60. Shors T. J., Gallegos R. A. and Breindl A. (1997) Transient and persistent consequences of acute stress on long-term potentiation (LTP), synaptic efficacy, theta rhythms and bursts in area CA1 of the hippocampus. Synapse 26, 209-217.
61. Stanton P. K. and Sarvey J. M. (1985) Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J. Neurosci. 5, 2169-2176.
62. Stewart C. A. and Reid I. C. (2000) Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology 148, 217-223.
63. Timpl R. and Brown J. C. (1994) The laminins. Matrix Biol. 14, 13729-13732.
64. Vaidya V. A., Siuciak J. A., Du F. and Duman R. S. (1999) Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89, 157-166.
65. Vetulani J. and Sulser F. (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cAMP-generating system in limbic forebrain. Nature 25, 7495-7496.
66. Wu C., Dias P., Kumar S., Lauder J. M. and Singh S. (1999) Differential expression of serotonin 5-HT2 receptors during rat embryogenesis. Dev. Neurosci. 21, 22-28.
67. Zhang J. M., Dix J., Langtimm-Sedlak C. J., Trusk T., Schroeder B., Hoffmann R., Strosberg A. D., Winslow J. W. and Sieber-Blum M. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. J. Neurobiol. 32, 262-280.